Cargando…
Success of Big Infectious Disease Reimbursement Policy in China
Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government’s intervention in large-scale infectious diseases is successful and efficient. Two potential strategie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036499/ https://www.ncbi.nlm.nih.gov/pubmed/32075479 http://dx.doi.org/10.1177/0046958020907788 |
_version_ | 1783500230754304000 |
---|---|
author | Nie, Kun-xi Wang, Chan Li, Xin-wu |
author_facet | Nie, Kun-xi Wang, Chan Li, Xin-wu |
author_sort | Nie, Kun-xi |
collection | PubMed |
description | Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government’s intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases. |
format | Online Article Text |
id | pubmed-7036499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-70364992020-03-03 Success of Big Infectious Disease Reimbursement Policy in China Nie, Kun-xi Wang, Chan Li, Xin-wu Inquiry Original Research Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government’s intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases. SAGE Publications 2020-02-20 /pmc/articles/PMC7036499/ /pubmed/32075479 http://dx.doi.org/10.1177/0046958020907788 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Nie, Kun-xi Wang, Chan Li, Xin-wu Success of Big Infectious Disease Reimbursement Policy in China |
title | Success of Big Infectious Disease Reimbursement Policy in
China |
title_full | Success of Big Infectious Disease Reimbursement Policy in
China |
title_fullStr | Success of Big Infectious Disease Reimbursement Policy in
China |
title_full_unstemmed | Success of Big Infectious Disease Reimbursement Policy in
China |
title_short | Success of Big Infectious Disease Reimbursement Policy in
China |
title_sort | success of big infectious disease reimbursement policy in
china |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036499/ https://www.ncbi.nlm.nih.gov/pubmed/32075479 http://dx.doi.org/10.1177/0046958020907788 |
work_keys_str_mv | AT niekunxi successofbiginfectiousdiseasereimbursementpolicyinchina AT wangchan successofbiginfectiousdiseasereimbursementpolicyinchina AT lixinwu successofbiginfectiousdiseasereimbursementpolicyinchina |